Deep-pocketed investors have adopted a bearish approach towards Cleanspark (NASDAQ:CLSK), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CLSK usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 69 extraordinary options activities for Cleans ...

It's time now for our 360 rounds. We'll bring in our panel to discuss this AMD and Open AI deal. Joining us today, Logan Gilland, an analyst at Juul Financial, and Brian Kello, the director of technology equity research at Morning Star.Logan, we'll start with you. You know, what are some of your takeaways from this deal. Initial impressions.Yeah, obviously open AI has kind of been the mightest touch lately for some of these companies, whether it's Nvidia or Oracle or now um coming around on this deal with A ...

Investors with a lot of money to spend have taken a bullish stance on Zscaler (NASDAQ:ZS).And retail traders should know.We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ZS, it often means somebody knows something is about to happen.So how do we know what these investors just did? Today, Benzinga's options scanner spotted 12 u ...

(Bloomberg) -- Janus Henderson Group Inc. will not tender its shares in U-blox Holding AG for Advent’s 1.05 billion Swiss franc ($1.3 billion) takeover bid of the chipmaker, according to people familiar with the matter. Janus Henderson, a top-10 U-blox shareholder with a 5% stake, is disappointed the firm’s management accepted an offer from Advent without spending more time exploring strategic options, the people said. The asset manager estimates fair value for U-blox would be about double Advent’s offer ...

In the current session, Dynatrace Inc. (NYSE:DT) is trading at $49.08, after a 0.15% decrease. Over the past month, the stock decreased by 4.53%, and in the past year, by 10.42%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. How Does Dynatrace P/E Compare to Other Companies?The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the indu ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. When Peter Schiff talks about housing, people tend to listen—he was one of the few voices who warned about the 2008 crash before it happened. Schiff, the CEO and chief global strategist of Euro Pacific Asset Management and host of "The Peter Schiff Show" podcast, is once again sounding the alarm. He argues that rising mortgage rates and inflated home prices are on a collision course, and that this time m ...

财务业绩 - 公司报告每股收益为0.85美元 超出市场预期的0.81美元 并高于去年同期的0.83美元 [1][6] - 公司报告实际收入约为17.2亿美元 超出市场预期的17.1亿美元 [2][6] - 公司实现了连续第五个季度的销量引领增长 [2][6] 增长驱动因素与战略 - 收入增长由对其高价产品的强劲需求推动 [2] - 公司对品牌、分销渠道扩张和创新的战略投资促进了增长 [2] - 公司通过有效的成本节约举措和可控行动管理推动了营业利润增长 [3] 市场估值与财务指标 - 公司市盈率约为23.65倍 市销率约为2.72倍 企业价值与销售额比率约为3.36倍 [4] - 公司债务与权益比率约为0.80 流动比率约为0.68 [5] 前景与挑战 - 公司因关税带来的挑战而下调了年度利润展望 [3][6] - 公司面临动态的全球贸易环境和成本上升 这影响了其毛利率 [3] - 公司适应外部动态的敏捷性为其持续长期增长奠定了基础 [5]

ORLANDO, Fla.--(BUSINESS WIRE)-- #BiotechNews--Hesperos, Inc. (Hesperos), a global leader focused on improving preclinical drug development, food, cosmetic, and chemical testing with its Human-on-a-Chip® (HoaC) single- and multi-organ systems platform, is pleased to announce the publication of a new peer- reviewed study, developed in collaboration with Bayer Consumer Health. The study introduces the first human- relevant microphysiological system (MPS) capable of modeling central nervous system (CNS) stress ...

Let's go outside of tech before we uh get out of this A block. Uh look at the home builders today. DR KB py toll.Uh Evercor has downgraded that group. Um they believe margins must bottom before the stocks can rerate. We do not believe that this will materialize in the next several months.Take a look at that move in DHI down 5%. You can cycle through the others. I'm sure that must tell a similar story, right.KB PY toll. Can we look at those guys. Um, I I bring this up in part because Jenny has made a move in ...

(Bloomberg) -- JPMorgan Chase & Co. Chief Executive Officer Jamie Dimon said he would welcome proposed changes that would ease US Securities and Exchange Commission requirements for quarterly earnings reports.  “The bigger problem wasn’t just reporting quarterly,” Dimon said Tuesday in an interview on Bloomberg TV. “It was forecasting, where CEOs get their back up against a wall. They have to meet these things — earnings — and then they start doing dumb stuff to meet earnings, and that kind of public pres ...